The public FDA record for Guangdong Ashmore Health Technology Co., Ltd. is narrow and specific. The applicant appears on a single 510(k), K262254, for a device named Hair Growth Comb (X-GC01), with a decision of substantially equivalent dated 23 September 2026. The submission was received on 2 July 2026 and reviewed under the traditional pathway without third-party review. Product code OAP places the device in the Physical Medicine panel, and the regulation cited is 21 CFR 890.5500 for laser, comb, hair devices at Class 2. The applicant address in the filing is in Foshan, China. [1][4][5]
The documented filing and its scope
K262254 was received 2 July 2026 and decided 23 September 2026 as substantially equivalent, with a statement rather than a summary in the record. The clearance type is traditional, the third-party flag is N, and the advisory committee is Physical Medicine. The device is listed as Hair Growth Comb (X-GC01) under product code OAP and regulation 890.5500, classified as Laser, Comb, Hair at Class 2. [1][4]
The indications text reproduced in the Innolitics record describes the Hair Growth Comb as indicated to treat androgenetic alopecia and promote hair growth in specified female and male pattern hair loss groups across defined Fitzpatrick skin types. That wording is the applicant's stated indication as published in that record; it is not evidence of measured clinical performance. [5]
Product code context
The OAP product code is described by HaRi as Laser, Comb, Hair under 21 CFR 890.5500, Class 2, with a Physical Medicine specialty and a light-emitting stimulator physical state. The same page reports 115 devices and 15 adverse events associated with the code, which describes the code's wider population rather than this applicant's record. [6]
The openFDA 510(k) endpoint returned 75 results for decisions dated 21 September through 31 December 2026, with a last-updated date of 28 September 2026. That figure is a query window count, not a count of this company's filings. [3]
Publication activity attributed to the company
A Biosensors article, "FLIM Reveals Red Light-Induced Changes in Murine Hair Follicles," lists Guangdong Ashmore Health Technology Co., Ltd., Foshan 528305, China, among author affiliations. The paper was published 22 April 2026 and concerns fluorescence lifetime imaging of murine hair follicles under red light. Its subject is murine tissue imaging, and the public information reports no device performance data for X-GC01. [8]
What the record does not establish
The public documents document one 510(k) clearance and no recalls. Arca, as of 18 November 2026, lists one 510(k) clearance for the company, the most recent dated 23 September 2026 for Hair Growth Comb (X-GC01). That count reflects the records Arca compiled and does not represent total company sales, total portfolio or safety performance. [7]
No parent, brand owner, website, customer list or manufacturing certification is verified in the public information. The Foshan address appears as the applicant address in the FDA filing and is not established as a headquarters. Commercial availability of X-GC01 is not documented. [1][4]
